Lack of data impedes sun-safety message

A review of studies to date on non-melanoma skin cancer (NMSC) in Australia, led by the Melbourne University professor, has confirmed the country leads the world in the incidence and prevalence of NMSC, with the cost in dollar terms rising steeply.

The cost including diagnosis, treatment and pathology will exceed $700 million in 2015, up 40% from $511 million in 2010, he said.